Stocks and Investing Stocks and Investing
Fri, June 18, 2021
Thu, June 17, 2021
Wed, June 16, 2021
Tue, June 15, 2021
Mon, June 14, 2021
Sun, June 13, 2021
Fri, June 11, 2021

Alethia Young Maintained (VRTX) at Buy with Decreased Target to $281 on, Jun 11th, 2021


Published on 2024-10-27 16:57:53 - WOPRAI
  Print publication without navigation


Alethia Young of Cantor Fitzgerald, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Decreased Target from $285 to $281 on, Jun 11th, 2021.

Alethia has made no other calls on VRTX in the last 4 months.



There are 2 other peers that have a rating on VRTX. Out of the 2 peers that are also analyzing VRTX, 0 agree with Alethia's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Alethia


  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $260 on, Monday, May 3rd, 2021